New therapeutic agents in thrombosis and thrombolysis / edited by Jane E. Freedman; Joseph Loscalzo
| Medienart: |
Buch |
|---|
| Erscheinungsjahr: |
c2009 |
|---|---|
| Erschienen: |
New York u.a.: Informa Healthcare ; c2009 |
| Ausgabe: |
3rd ed. |
| Reihe: |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Freedman, Jane E. [Sonstige Person] |
|---|
| Links: |
|---|
| ISBN: |
|---|
| Nlm: |
W1 QZ 170 |
|---|---|
| BKL: | |
| Themen: |
Antithrombotikum |
| Anmerkungen: |
Includes bibliographical references and index |
|---|
| Umfang: |
xv, 690 S. ; graph. Darst. ; 26 cm |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
583188281 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 583188281 | ||
| 003 | DE-627 | ||
| 005 | 20230905072821.0 | ||
| 007 | tu | ||
| 008 | 081022s2009 xxu||||| 00| ||eng c | ||
| 010 | |a 2008042440 | ||
| 020 | |a 1420069233 |c hardcover : alk. paper |9 1-4200-6923-3 | ||
| 020 | |a 9781420069235 |c : hardcover : alk. paper |9 978-1-4200-6923-5 | ||
| 035 | |a (DE-627)583188281 | ||
| 035 | |a (DE-599)GBV583188281 | ||
| 035 | |a (OCoLC)837029024 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 044 | |c XD-US |c XA-GB | ||
| 050 | 0 | |a RC694.3 | |
| 060 | 0 | |a W1 | |
| 060 | 0 | |a QZ 170 | |
| 082 | 0 | |a 616.1/3506 |q LOC |2 22 | |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.86 |2 bkl | ||
| 245 | 1 | 0 | |a New therapeutic agents in thrombosis and thrombolysis |c edited by Jane E. Freedman; Joseph Loscalzo |
| 250 | |a 3rd ed. | ||
| 264 | 1 | |a New York [u.a.] |b Informa Healthcare |c c2009 | |
| 300 | |a xv, 690 S. |b graph. Darst. |c 26 cm | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 490 | 1 | |a Fundamental and clinical cardiology |v 65 | |
| 500 | |a Includes bibliographical references and index | ||
| 650 | 0 | |a Thrombolytic therapy | |
| 650 | 0 | |a Fibrinolytic agents | |
| 650 | 0 | |a Thrombosis | |
| 650 | 2 | |a Thrombolytic Therapy | |
| 650 | 2 | |a Fibrinolytic Agents |x therapeutic use | |
| 650 | 2 | |a Hemostasis |x drug effects | |
| 650 | 2 | |a Platelet Aggregation Inhibitors |x therapeutic use | |
| 650 | 2 | |a Thrombosis |x drug therapy | |
| 689 | 0 | 0 | |D s |0 (DE-588)4124936-7 |0 (DE-627)105743925 |0 (DE-576)209572329 |a Antithrombotikum |2 gnd |
| 689 | 0 | 1 | |D s |0 (DE-588)4017040-8 |0 (DE-627)10633123X |0 (DE-576)208918183 |a Fibrinolyse |2 gnd |
| 689 | 0 | |5 (DE-627) | |
| 700 | 1 | |a Freedman, Jane E. |4 oth | |
| 700 | 1 | |a Loscalzo, Joseph |4 oth | |
| 830 | 0 | |a Fundamental and clinical cardiology |v 65 |9 6500 |w (DE-627)610027999 |w (DE-576)9610027997 |w (DE-600)2518188-9 |7 ns | |
| 856 | 4 | 2 | |u http://www.gbv.de/dms/bowker/toc/9781420069235.pdf |m V:DE-601 |m X:Bowker |q pdf/application |v 2010-12-19 |x Verlag |y Inhaltsverzeichnis |3 Inhaltsverzeichnis |
| 912 | |a GBV_ILN_20 | ||
| 912 | |a ISIL_DE-84 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-DE-84 | ||
| 936 | b | k | |a 44.38 |j Pharmakologie |0 (DE-627)106409743 |
| 936 | b | k | |a 44.86 |j Hämatologie |0 (DE-627)106409409 |
| 951 | |a BO | ||
| 953 | |2 045F |a 616.1/3506 | ||
| 980 | |2 20 |1 01 |x 0084 |b 1101897066 |c 00 |f --%%-- |d 2898-2595 |e --%%-- |j --%%-- |y k |z 26-01-10 | ||
| 984 | |2 20 |1 01 |x 0084 |a 84$028982595 | ||